Skip to main content

Axillary Reverse Mapping: ARM

  • Chapter
  • First Online:
Breast Cancer Management for Surgeons

Abstract

Any surgical intervention in the axilla may potentially result in lymphoedema of the upper extremity. The concordance of the sentinel nodes draining the upper extremity and sentinel nodes draining the breast is the probable cause of lymphoedema after SLN biopsy in breast cancer. Axillary reverse mapping (ARM) is a feasible technique that may reduce lymphoedema rates in breast cancer patients while preserving the oncological safety of the procedure. Preservation of axillary reverse mapping nodes results in a low incidence of lymphoedema during sentinel node biopsy and axillary node dissection. The potential benefit of the ARM technique needs to be evaluated in a controlled randomized trial to confirm the findings of the reported institutional protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500.

    Article  PubMed  Google Scholar 

  2. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959–72.

    Article  PubMed  Google Scholar 

  3. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol. 2008;26(35):5689–96.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536–42.

    Article  PubMed  Google Scholar 

  5. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. JNCI. 2006;98(9):599–609.

    Article  PubMed  Google Scholar 

  6. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23(19):4312.

    Article  PubMed  Google Scholar 

  7. Miller CL, Specht MC, Skolny MN, Horick N, Jammallo LS, O’Toole J, et al. Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat. 2014;144(1):71–7.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102:111–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Suami H, Taylor GI, Pan WR. The lymphatic territories of the upper limb anatomical study and clinical implications. Plast Reconst Surg. 2007;119(6):1813–22.

    Article  CAS  PubMed  Google Scholar 

  10. Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14:1890–5.

    Article  PubMed  Google Scholar 

  11. Nos C, Leiseur B, Clough KB, et al. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. 2007;14:2490–6.

    Article  PubMed  Google Scholar 

  12. Pavlista D, Eliska O. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla – a lesson from the past – contribution to the concept of axillary reverse mapping. Eur J Surg Oncol. 2012;38(5):390–4.

    Article  CAS  PubMed  Google Scholar 

  13. Pavlista D, Eliska O. Relationship between the lymphatic drainage of the breast and the upper extremity: a postmortem study. Ann Surg Oncol. 2012;19(11):3410–5.

    Article  PubMed  Google Scholar 

  14. Boneti C, Korourian S, Diaz Z, Santiago C, Mumford S, Adkins L, et al. Scientific impact award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg. 2009;198:482–7.

    Article  PubMed  Google Scholar 

  15. Casabona F, Bogliolo S, Valenzano Menada M, Sala P, Villa G, Ferrero S. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol. 2009;16:2459–63.

    Article  PubMed  Google Scholar 

  16. Han JW, Seo YJ, Choi JE, Kang SH, Bae YK, Lee SJ. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer. 2012;15:91–7.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ponzone R, Cont NT, Maggiorotto F, et al. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol. 2009;27(33):5547–51.

    Article  PubMed  Google Scholar 

  18. Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol. 2013;39:880–6.

    Article  CAS  PubMed  Google Scholar 

  19. Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS. Axillary reverse mapping: five-year experience. Surgery. 2014;156:1261–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gennaro M, Maccauro M, Sigari C, Casalini P, Bedodi L, Conti AR, et al. Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema. Eur J Surg Oncol. 2013;39:1341–5.

    Article  CAS  PubMed  Google Scholar 

  21. Yue T, Zhuang D, Zhou P, Zheng L, Fan Z, Zhu J, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer. 2015;15:301–6.

    Article  PubMed  Google Scholar 

  22. Rubio IT, Cebrecos I, Peg V, Esgueva A, Mendoza C, Cortadellas T, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer. J Surg Oncol. 2012;106(1):89–93.

    Article  PubMed  Google Scholar 

  23. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010;116(11):2543–8.

    PubMed  PubMed Central  Google Scholar 

  24. Kuusk U, Seyednejad N, McKevitt EC, Dingee CK, Wiseman SM. Axillary reverse mapping in breast cancer: a Canadian experience. J Surg Oncol. 2014;110(7):791–5.

    Article  PubMed  Google Scholar 

  25. Noguchi M, Noguchi M, Nakano Y, Ohno Y, Kosaka T. Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol. 2012;105(3):229–34.

    Article  PubMed  Google Scholar 

  26. Ikeda K, Ogawa Y, Kajino C, et al. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients. EJSO. 2014;40(7):818–23.

    Article  CAS  PubMed  Google Scholar 

  27. Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine florescence imaging in patients with breast cancer. J Surg Oncol. 2010;101:217–21.

    PubMed  Google Scholar 

  28. Sakurai T, Endo M, Shimizu K, et al. Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies. J Surg Oncol. 2014;109(6):612–5.

    Article  PubMed  Google Scholar 

  29. Noguchi M, Noguchi M, Ohno Y, et al. Feasibility study of axillary reverse mapping for patients with clinically node negative breast cancer. EJSO. 2016;42(5):650–6.

    Article  CAS  PubMed  Google Scholar 

  30. Klimberg VS. A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Oncol. 2008;97:563–4.

    Article  PubMed  Google Scholar 

  31. Boneti C, Badgwell B, Robertson Y, Korourian S, Adkins L, Klimberg V. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy. Minerva Ginecol. 2012;64(5):421–30.

    CAS  PubMed  Google Scholar 

  32. Tummel E, Ochoa D, Korourian S, Betzold R, Adkins L, et al. Does axillary reverse mapping prevent lymphedema after lymphadenectomy? Ann Surg. 2016;265(5):987–92.

    Article  Google Scholar 

  33. Han C, Yang B, Zuo W, Zheng G, Yang L, et al. The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and Meta-analysis of prospective studies. PLOS One. 2016; doi:10.1371/journal.pone.0150285.

  34. Connor C, McGinness M, Mammen J, Ranallo L, Lafaver S, Klemp J, et al. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer. Ann Surg Oncol. 2013;20:3303–7.

    Article  PubMed  Google Scholar 

  35. Britton TB, Solanki CK, Pinder SE, Mortimer PS, Peters AM, Purushotham AD. Lymphatic drainage pathways of the breast and the upper limb. Nucl Med Commun. 2009;30(6):427–30.

    Article  PubMed  Google Scholar 

  36. Schunemann E, Doria MT, Silvestre JB, et al. Prospective study evaluating oncological safety of axillary reverse mapping. Ann Surg Oncol. 2014;21:2197–202.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Deng H, Chen L, Jia W, et al. Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. J Cancer Res Clin Oncol. 2011;137(12):1869–74.

    Article  PubMed  Google Scholar 

  38. Gobardhan PD, Wijsman JH, van Dalen T, Klompenhower EG, et al. ARM: axillary reverse mapping – the need for selection of patients. Eur J Surg Oncol. 2012;38(8):657–61.

    Article  CAS  PubMed  Google Scholar 

  39. Nos C, Kaugmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008;15(9):2550–5.

    Article  PubMed  Google Scholar 

  40. Beek MA, Gobardhan PD, Klompenhouwer EG, Rutten HJ, Voogd AC, Luiten EJ. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients. Eur J Surg Oncol. 2015;41(1):59–63.

    Article  CAS  PubMed  Google Scholar 

  41. Kang SH, Choi JE, Jeon YS, Lee SJ, Bae YK. Preservation of lymphatic drainage from arm in breast cancer surgery: is it safe? Cancer Res. 2009;69(Suppl. 2):87s.

    Google Scholar 

  42. Khandelwal R, Poovamma CU, Shilpy C, Prema M, Anthony P. Axillary reverse mapping: is it feasible in locally advanced breast cancer patients? Breast Dis. 2014;34(4):151–5. PubMed

    Article  PubMed  Google Scholar 

  43. Pasko JL, Garreau J, Carl A, Ansteth M, Glissmeyer M, Johnson N. Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer. Am J Surg. 2015;209(5):890–5. PubMed

    Article  PubMed  Google Scholar 

  44. Ahmed M, Rubio IT, Kovacs T, Klimberg VS, Douek M. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016;103(3):170–8.

    Article  CAS  PubMed  Google Scholar 

  45. Martelli G, Miceli R, Daidone MG, Vetrella G, Cerrotta AM, Piromalli D, et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2011;18:125–33.

    Article  PubMed  Google Scholar 

  46. Klompenhouwer EG, Gobardhan PD, Beek MA, Voogd AC, Luiten EJ. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial. Trials. 2013;14:111.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Boccardo F, Casabona F, De Cian F, et al. Lymphedema microsurgical preventive healing approach (LYMPHA): a new technique for primary prevention of arm lymphedema. Ann Surg Oncol. 2009;16:703–8.

    Article  PubMed  Google Scholar 

  48. Beek MA, Tetteroo E, Luiten EJ, et al. Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy. Eur J Surg Oncol. 2016;42(5):672–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabel T. Rubio MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Rubio, I.T., Luiten, E.J.T., Suzanne Klimberg, V. (2018). Axillary Reverse Mapping: ARM. In: Wyld, L., Markopoulos, C., Leidenius, M., Senkus-Konefka, E. (eds) Breast Cancer Management for Surgeons. Springer, Cham. https://doi.org/10.1007/978-3-319-56673-3_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56673-3_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56671-9

  • Online ISBN: 978-3-319-56673-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics